Finally, As the majority of patients in this study were treated with PD-1 monotherapy, and fewer patients received other treatment regimens, our ability to assess the impact of different treatment protocols, particularly dual ICI combinations, on the development of myocarditis was limited. This evidence concerns the gene PDCD1 and myocarditis.